ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 182 filers reported holding ASCENDIS PHARMA A/S in Q1 2022. The put-call ratio across all filers is 0.64 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,785,000 | -97.8% | 20,000 | -97.4% | 0.01% | -98.0% |
| Q1 2023 | $82,678,414 | +80.7% | 771,110 | +105.8% | 0.26% | +64.1% |
| Q4 2022 | $45,763,332 | +15.4% | 374,710 | -2.5% | 0.16% | -1.3% |
| Q3 2022 | $39,672,000 | +1119.2% | 384,200 | +997.7% | 0.16% | +1028.6% |
| Q2 2022 | $3,254,000 | -78.4% | 35,000 | -68.8% | 0.01% | -76.7% |
| Q4 2021 | $15,094,000 | +2.6% | 112,200 | +21.5% | 0.06% | -7.7% |
| Q3 2021 | $14,713,000 | +31.4% | 92,309 | +8.5% | 0.06% | +30.0% |
| Q2 2021 | $11,195,000 | +148.2% | 85,100 | +143.1% | 0.05% | +138.1% |
| Q1 2021 | $4,511,000 | -35.1% | 35,000 | -16.1% | 0.02% | -38.2% |
| Q4 2020 | $6,955,000 | -14.9% | 41,700 | -42.6% | 0.03% | -48.5% |
| Q1 2020 | $8,175,000 | – | 72,600 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 7,387,900 | $1,177,557,000 | 16.32% |
| Q Global Advisors, LLC | 66,714 | $10,634,000 | 8.85% |
| Ghost Tree Capital, LLC | 120,000 | $19,127,000 | 5.59% |
| Vivo Capital, LLC | 760,606 | $121,233,000 | 5.44% |
| Spyglass Capital Management LLC | 1,378,887 | $219,781,000 | 5.04% |
| Avoro Capital Advisors LLC | 1,980,000 | $315,592,000 | 4.96% |
| Eversept Partners, LP | 445,203 | $70,960,906 | 4.93% |
| Sofinnova Investments, Inc. | 499,824 | $79,667,000 | 4.72% |
| Eventide Asset Management | 1,748,648 | $278,717,000 | 3.68% |
| Baker Brothers Advisors | 4,541,604 | $723,886,000 | 3.18% |